Pelthos Therapeutics Inc（PTHS）價格預測PTHSPelthos Therapeutics Inc

Alphio's PTHS stock price prediction model matches the current Pelthos Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.79 (+2.92%). The 1-week path is $9.88 (+3.90%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Pelthos Therapeutics Inc is not a strong buy at the moment due to its current price of $11.52, which is significantly below its 52-week high of $37.50. The RSI is at 31.083, indicating that the stock is oversold, but the recent performance shows a 5-day change of -24.21% and a year-to-date change of -60.88%. While there are positive catalysts such as revenue growth to $10.7 million in Q1 2026 and a strategic merger with Castle Creek, the company still faces significant financial challenges, including a net loss of $10.2 million in Q1 and a forward P/E ratio of 0, suggesting uncertainty in profitability. The main risk is the high volatility in prescription trends for its lead product ZELSUVMI, which analysts have noted as flat. Therefore, while there may be potential for recovery, the current financial instability and market conditions suggest a cautious approach.

Pelthos Therapeutics Inc (PTHS) last closed at $9.5100002, gaining +2.26%. These facts feed the 1-day and 1-week PTHS price prediction above.